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Abstract  
Recipients of solid organ transplantation are, because of immunosuppressive therapy, at high risk to develop opportunistic infections including 
tuberculosis (TB). The incidence, clinical manifestations, and optimal diagnostic tests of this disease in this population have not been adequately 
defined. In this paper, we report a case of 13 year-old boy who developed pulmonary tuberculosis following a second renal transplantation from a 
deceased donor. The described case points diagnostic difficulties of the tuberculosis disease which are due to insidious and non specific clinical 
presentation. Also, the treatment is delicate because interaction between immunosuppressive drugs and antituberculosis drugs. 
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Introduction 
 
It is well documented that immunosuppressive therapy exposes 
solid organ recipients to many serious complications including 
opportunistic infections [1]. In such immunocompromised patients, 
tuberculosis re-emerged as a serious complication frequently 
observed with atypical presentation causing delay in diagnosis [2]. 
The most of published cases were described in adult recipients from 
endemic area. In children tuberculosis has been rare and the few 
cases that have been reported [3]. We report here a rare case of 
pulmonary tuberculosis in a pediatric renal recipient with good 
outcome after conventional anti tuberculosis therapy. 
  
  
Patient and observation 
 
A 13 year-old Tunisian male was admitted in our department of 
paediatric nephrology on October 2009 with a week-history of fever 
and asthenia. He was suffering from end-stage renal failure 
attributed to a vesico-ureteral reflux discovered in 2003. In 2007, 
the patient had a pre-emptive renal transplant from a living donor. 
The post-operative course was characterised by an acute ischemia 
of the transplant due to a venous renal thrombosis that lead to a 
detransplantation. A regular peritoneal dialysis was initiated on June 
2007. A second renal transplantation was performed on June 2009 
from a 27 year-old deceased donor. The post operative course was 
uneventful. The patient was maintained on Prednisone 10 mg/day, 
mycophenolate mofetil 1500 mg/day, and Cyclosporine 75 mg twice 
per day with adequate renal function. Three months after 
transplantation, the patient was hospitalized in our department for 
fever with asthenia. The physical examination on admission 
revealed asthenic patient, with temperature of 38.5°C, blood 
pressure of 110/70 mm Hg, pulse rate of 90 /min, and inspiratory 
rhonchi with decreased breath sound over both bases. There were 
no peripheral lymph nodes or hepatosplenomegaly. Laboratory 
investigations revealed hematocrit of 38%, white blood cell count of 
8300/mm3, platelet count of 220.000/mm3, blood urea nitrogen of 
6.8 mmol/l, serum creatinine level of 75 µmol/l, C reactive protein 
serum level of 88.5mg/l and erythrocyte sedimentation rate of 51 
mm/hour. Liver function tests and lipid profile were normal. The 
protein electrophoresis showed a total protein serum level of 65g/l, 
(Albumin 33.9g/l, α1 globulin 5.8g/l, α2 globulin 9.6g/l, β1 globulin 
3.9g/l, β2 globulin 3.4g/l, γ globulin 8.3g/l). The chest x-ray 
revealed opacity in the right middle zone and superior mediastinal 
enlargement (Figure 1). A thoracic CT scan showed cavitatory 
pneumonia of the right lower lobe and anterior mediastinal mass on 
right and left main stem bronchi corresponding to lymph nodes 
(Figure 2and Figure 3). Regarding the clinical, biological and 
radiological findings, three diagnoses were suspected: pneumonia, 
pulmonary tuberculosis and pulmonary aspergillosis. By considering 
the history of the patient and the fact that our country is endemic, 
our diagnosis was quickly directed towards pulmonary tuberculosis 
despite the negativity of tuberculin skin test. The search of 
mycobacterium tuberculosis by gastric tubing was negative but the 
diagnosis was made by the study of sputum specimens aspirated 
during bronchoalveolar lavage that revealed the presence of 
mycobacterium tuberculosis. In vitro studies showed the organisms 
to be fully susceptible to all antituberculosis drugs. Four drugs, 
isoniazid (INH), Rifadine (RIF), Ethambutol(EMB) and pyazolin( PZA) 
were administered orally with the usual doses. The dose of 
corticosteroids was increased and that of cyclosporine was adjusted 
to maintain trough plasma levels in recommended therapeutic 
range. To prevent the neurological side effects of INH we prescribed 
a pyridoxine in dose of 50 mg per day. The Outcome under 
antitubercular therapy has so far been favourable, with prolonged 
apyrexia and regression of the pulmonary abnormalities. This 
regimen, maintained during 18 months, was well tolerated without 





The incidence of tuberculosis after solid organ transplantation is 
higher compared with the general population [1-3]. The use of 
corticosteroids and immunosuppressive drugs interfere with T-cell-
mediated function, resulting in decreased host resistance to 
infection [4-7]. A longer duration of dialysis before transplantation, 
a previous history of infection, and a poor socioeconomic class are 
also reported as risk factors [7]. Tuberculosis generally occurs after 
6 months of renal transplantation [5,6]. In our patient, TB was 
diagnosed early, three months after a second renal transplant. 
There was no evidence of contact with individuals having active 
tuberculosis. The mode of contamination is probably a reactivation 
of latent infection or a transmission by the donor kidney. The clinical 
presentation of TB may be unusual and subtle in an 
immunosuppressed transplant recipient [5]. In every case of 
prolonged fever and unusual clinical manifestations, tuberculosis 
should be considered especially in endemic countries [5,7]. The 
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confirmation of mycobacterium tuberculosis infection is difficult. 
Moreover, the bacteriologic culture may be negative and the 
tuberculin skin tests are often negative in the transplanted 
population [8]. In our patient, the search of mycobacterium 
tuberculosis by gastric tubing was negative but the diagnosis was 
made fortunately by the traditional tests: Zeihl-Neelsen staining and 
culture of sputum specimens aspirated during bronchoalveolar 
lavage. So, this diagnostic procedure should be considered in the 
diagnosis of pulmonary tuberculosis in children and adults. It 
allowed a better rate of diagnosis. New diagnostic tests have been 
developed recently to improve sensitivity and allow a rapid diagnosis 
of tuberculosis particularly in patients with culture-negative 
tuberculosis. The latest technique is especially the blood test 
measuring the Interferon-gamma released by stimulated T cells [8]. 
However, it should not be used in the first instance for diagnosis of 
active TB. Apart from the diagnostic difficulties, TB in transplant 
patients is a real therapeutic problem. Some authors reported an 
increased rate of acute rejection and a higher rate of graft loss 
because of interactions between CyA, prednisone and Rifampicin 
[5,6]. An adequate and regular monitoring of immunosuppressive 
drugs avoids the risk of rejection. The neurotoxicity of cyclosporine 
is well documented [7] and can be increased by INH; we then 
prescribe systematically pyridoxine to our patient. The prevention of 
TB is that difficult to achieve in solid organs transplanted patients. 
The American Thoracic Society has recommended several years 
ago, a prophylactic INH administration to Mantoux-positive patients 
[8,9]. This strategy, however, is unlikely to be applicable in 
endemic areas, both because of a high degree of Mantoux positivity 
in the general population as well as the high frequency of false 
negative tests among chronic renal failure patients. Routine INH 





The clinical presentation of TB after renal transplantation may be 
different from that of the general population, which makes diagnosis 
a challenging task. The variety of immunosuppressive drugs which 
these patients receive and the consequent suppression of cell-
mediated immunity should theoretically place them at an increased 
risk for developing active tuberculosis. Multiple methods should be 
considered in the diagnostic approach to tuberculosis since none is 
totally efficient. Finally, the treatment of tuberculosis must take into 
consideration the drug toxicity and interactions. 
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Figure 1: Chest radiography: superior mediastinal enlargement 
Figure 2: Chest computed tomography: anterior mediastinal mass 
on right and left main stem bronchi 
Figure 3: Chest computed tomography: cavitatory pneumonia of 
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Figure 2: Chest computed tomography: anterior mediastinal mass on right and 




Figure 3: Chest computed tomography: cavitatory pneumonia of right 
lower lobe 
 
